When you pick up a carton of milk or a package of chicken at the grocery store, you’re benefiting from decades of veterinary pharmaceutical innovation. Veterinary drugs play a vital role in modern food production, helping farmers maintain healthy, productive animals while ensuring a safe and abundant food supply. The FDA’s Center for Veterinary Medicine ensures that these drugs are safe and effective, and that food from treated animals is safe for people to eat. From antibiotics that fight bacterial infections to growth promoters that improve feed efficiency, these pharmaceuticals are essential tools in livestock management.
Table of Contents
- Why veterinary drugs matter in food production
- Antimicrobials: Fighting bacterial and fungal infections
- Common classes of antimicrobials
- Antiparasitic drugs: Managing internal and external parasites
- Steroid hormones and growth promotion
- Beta-agonists: Repartitioning nutrients for lean growth
- Non-steroidal anti-inflammatory drugs for pain management
- Approved uses in food animals
- Proper administration and minimizing residues
- Withdrawal periods and maximum residue limits
- Balancing animal health with food safety
Why veterinary drugs matter in food production
Food-producing animals face numerous health challenges that can impact both their welfare and productivity. Veterinary drugs are used to prevent or treat animal diseases, and when rationally administered following Good Veterinary Practices, they greatly contribute to improving the production of food of animal origin. These medications help farmers respond to disease outbreaks quickly, reduce animal suffering, and maintain the health of entire herds or flocks.
The global demand for animal protein continues to rise, making efficient livestock production more important than ever. Antiparasitic drugs currently represent the second-largest position in the world animal health market at 23%, with antibiotics ranking third at 16% of sales. This reflects their critical role in supporting animal health and food security worldwide.
Antimicrobials: Fighting bacterial and fungal infections
Antimicrobials represent the most widely used category of veterinary drugs in food-producing animals. These compounds include antibiotics that target bacteria and antifungals that combat fungal infections. When antimicrobials are used in animals, FDA’s Center for Veterinary Medicine works to ensure their use supports antimicrobial stewardship to combat resistance.
Common classes of antimicrobials
Several major antimicrobial classes are approved for use in livestock. Beta-lactams like penicillin work by disrupting bacterial cell wall formation. Tetracyclines, among the most commonly used antibiotics, interfere with bacterial protein synthesis. Fluoroquinolones target bacterial DNA replication, while sulfonamides block bacterial folate synthesis. Each class has specific indications and works through different mechanisms to control bacterial infections.
The selection of the appropriate antimicrobial depends on the specific pathogen, the animal species, and the type of infection being treated. Veterinarians must consider factors such as drug pharmacokinetics, withdrawal periods, and potential for resistance development when prescribing these medications.
Antiparasitic drugs: Managing internal and external parasites
Parasites pose significant health and economic challenges in livestock production. FDA’s Center for Veterinary Medicine created the Antiparasitic Resistance Management Strategy to promote sustainable use of approved antiparasitic drugs in cattle, small ruminants, and horses.
Antiparasitic drugs fall into two main categories: those targeting internal parasites (endoparasites) like roundworms, tapeworms, and flukes, and those controlling external parasites (ectoparasites) such as ticks, mites, and flies. The macrocyclic lactones, including ivermectin and moxidectin, are particularly effective against both internal and external parasites. Benzimidazoles target intestinal worms, while organophosphates and pyrethroids help control external parasites.
Regular deworming programs and strategic parasite management help maintain animal health and productivity. However, overuse of antiparasitic drugs has led to resistance concerns, making it essential to use these medications judiciously and combine them with management practices like pasture rotation and quarantine protocols for new animals.
Steroid hormones and growth promotion
Anabolic steroid hormones are the class of hormonal growth promotants most widely used in production, almost exclusively in cattle and only approved for use in ruminant species. These include natural hormones like estradiol, testosterone, and progesterone, as well as synthetic compounds such as trenbolone acetate and zeranol.
These hormones work by increasing protein synthesis in muscle tissue while reducing fat deposition. They bind to specific receptors in skeletal muscle, promoting nitrogen retention and enhanced muscle growth. The result is improved feed efficiency and faster growth rates, which can reduce production costs and environmental impact per unit of meat produced.
However, hormone use in livestock remains controversial. The EU has banned beef produced using growth-promotant implants since 1981, although subsequent findings by scientific experts indicate that appropriate use of approved growth-promoting hormones poses no health risk to consumers. In the United States, these products remain approved under strict regulatory oversight, with established maximum residue limits to ensure consumer safety.
Beta-agonists: Repartitioning nutrients for lean growth
Beta-agonists represent another class of growth-promoting compounds used in livestock production. Beta-adrenergic receptor agonists are used to preferentially increase nutrient partitioning from fat to muscle. Common examples include ractopamine, zilpaterol, and clenbuterol.
These compounds work by binding to beta-receptors in muscle and fat tissue, stimulating muscle protein synthesis while promoting fat breakdown. The result is a leaner carcass with increased muscle mass and improved feed conversion efficiency. Beta-agonists are typically administered during the final weeks before slaughter to maximize their effects on carcass composition.
Like hormones, beta-agonists face regulatory restrictions in many countries. The EU, China, and Russia have banned their use in food-producing animals, while other countries have adopted maximum residue limits established by the Codex Alimentarius Commission. In the United States, ractopamine is approved for use in swine, cattle, and turkeys under specific conditions with established withdrawal periods.
Non-steroidal anti-inflammatory drugs for pain management
Veterinary nonsteroidal anti-inflammatory drugs are commonly used to control fever, pain, and other signs of inflammation in animals. These medications work by inhibiting cyclooxygenase enzymes, which reduces the production of prostaglandins involved in inflammation, pain, and fever.
Approved uses in food animals
In food-producing species, NSAIDs have limited but important applications. For cattle, NSAIDs are approved to control fever from mastitis and bovine respiratory disease, control fever and inflammation from endotoxemia, and control pain from foot rot. In pigs, they’re used to control fever from swine respiratory disease.
Common veterinary NSAIDs include flunixin meglumine, ketoprofen, and meloxicam. These drugs provide pain relief during procedures like castration and dehorning, help manage lameness and musculoskeletal disorders, and reduce fever associated with infections. However, NSAIDs must be used carefully, as they can cause side effects including gastrointestinal ulcers, kidney problems, and liver damage if not administered according to label directions.
Proper administration and minimizing residues
The effectiveness of veterinary drugs and the safety of the food supply both depend on proper drug administration. For drugs used in food-producing animals, sponsors must prove that it’s safe for people to eat food from treated animals, such as meat, milk, and eggs.
Dosage accuracy is critical. Underdosing may lead to treatment failure and contribute to antimicrobial resistance, while overdosing increases the risk of adverse effects and drug residues in animal products. The route of administration-whether oral, intramuscular, subcutaneous, or intravenous-affects how the drug is absorbed and distributed in the body, which influences both therapeutic effectiveness and residue depletion.
Withdrawal periods and maximum residue limits
Maximum residue limits are the maximum concentration of residue resulting from the use of a veterinary drug that is recommended to be legally permitted in food. These limits are established based on extensive safety studies and represent the highest level of drug residue considered safe for human consumption.
Withdrawal periods specify the time that must elapse between the last drug administration and when an animal can be slaughtered or when milk or eggs can be used for human consumption. These periods are designed to ensure that drug residues fall below established maximum residue limits. Veterinarians and producers must strictly adhere to these withdrawal periods to maintain food safety.
Record-keeping plays a vital role in residue prevention. Producers should maintain detailed records of all drug treatments, including the drug name, dosage, route of administration, treatment dates, and withdrawal periods. This documentation helps ensure compliance with regulations and provides traceability if residue violations occur.
Balancing animal health with food safety
The responsible use of veterinary drugs requires balancing the need to treat animal diseases with the imperative to protect public health. FDA developed a five-year action plan for supporting antimicrobial stewardship in veterinary settings, recognizing that judicious use of these medications is essential for preserving their effectiveness.
Veterinarians must follow principles of antimicrobial stewardship, which include using the narrowest spectrum antibiotic effective against the target pathogen, employing appropriate dosages and treatment durations, and considering alternatives to antimicrobial therapy when appropriate. For food-producing animals, this also means selecting drugs with shorter withdrawal periods when clinically appropriate and ensuring proper identification of treated animals to prevent premature slaughter or milk harvest.
Producers can support food safety by implementing disease prevention strategies that reduce the need for drug treatments. These include maintaining good biosecurity, providing proper nutrition, ensuring adequate housing and ventilation, managing stress, and working with veterinarians to develop comprehensive herd health programs. Prevention is always preferable to treatment, both for animal welfare and food safety.
What do you think? How can the livestock industry continue to balance the need for veterinary drugs to ensure animal health with growing concerns about drug residues and antimicrobial resistance? What role should consumers play in supporting sustainable livestock production practices?
References
- https://www.fda.gov/animal-veterinary/animal-health-literacy/fdas-role-protecting-animal-health
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8532868/
- https://www.fda.gov/animal-veterinary/safety-health/antimicrobial-resistance
- https://www.fda.gov/animal-veterinary/safety-health/new-antiparasitic-drugs-needed-sheep-and-goats
- https://www.merckvetmanual.com/pharmacology/growth-promotants-and-production-enhancers/overview-of-growth-promotants-and-production-enhancers-in-animals
- https://www.fda.gov/animal-veterinary/product-safety-information/veterinary-nonsteroidal-anti-inflammatory-drugs-nsaids
- https://www.fda.gov/animal-veterinary/animal-health-literacy/idea-marketplace-journey-animal-drug-through-approval-process
Leave a Reply